AstraZeneca promotes oncology exec to CMO; Pfizer replaces retiring chief dealmaker as war chest expands

Cristian Massacesi

The biggest bright spot for AstraZeneca over the last few years has been its work in oncology, as CEO Pascal Soriot has helped shepherd blockbusters Imfinzi, Lynparza, and Calquence, among other cancer medicines.

One of the top executives from the cancer division is now...

Click to view original post